GnRH agonist and antagonist: Options for endometriosis pain treatment
GnRH agonists and antagonists offer an aggressive, successful, albeit expensive, treatment option for endometriosis pain by acting on endometrial lesions and potentially aiding infertility management.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This peer-reviewed 2006 article discusses the development and mechanisms of endometriosis-associated pain and reviews therapeutic options, focusing on GnRH agonists and antagonists. It describes how, although available treatments generally do not resolve the underlying disease process, GnRH analogs may act on endometrial lesions and can provide an aggressive alternative for managing pain, while noting the class is relatively expensive and involved to implement. The paper also frames its discussion as primarily oriented to pain, with an additional note that similar medical manipulations may relate to infertility management by potentially reducing the need for aggressive or emergency surgery in young women. This paper is centrally about endometriosis—specifically, it reviews GnRH agonist and antagonist options for endometriosis-associated pain treatment.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
1,652 characters
· extracted from
oa-html
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (51)
- Administration of Nasal Nafarelin as Compared with Oral Danazol for Endometriosis via openalex
- Bone loss during gonadotropin releasing hormone agonist treatment and use of nasal calcitonin via openalex
- Buserelin versus danazol in the treatment of endometriosis-associated infertility via openalex
- Danazol in the Treatment of Endometriosis via openalex
- Depot leuprolide versus danazol in treatment of women with symptomatic endometriosis via openalex
- GnRH II as a possible cytostatic regulator in the development of endometriosis via openalex
- Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas via openalex
- Gonadotropin-releasing hormone agonist induces apoptosis and reduces cell proliferation in eutopic endometrial cultures from women with endometriosis via openalex
- Gonadotropin-releasing hormone agonist inhibits estrone sulfatase expression of cystic endometriosis in the ovary via openalex
- Gonadotropin-releasing hormone agonist treatment reduced serum interleukin-6 concentrations in patients with ovarian endometriomas via openalex
- Hormone treatment of endometriosis: The estrogenthreshold hypothesis via openalex
- Induction of an angiogenic phenotype in endometriotic stromal cell cultures by interleukin-1 via openalex
- Is It Possible to Prevent Bone Loss in Young Women Treated with Luteinizing Hormone-Releasing Hormone Agonists? via openalex
- Leuprolide Acetate Depot and Hormonal Add-Back in Endometriosis: A 12-Month Study via openalex
- Long-term use of gonadotropin-releasing hormone analogs and hormone replacement therapy in the management of endometriosis: a randomized trial with a 6-year follow-up via openalex
- Medical management of endometriosis and infertility via openalex
- Nafarelin in the treatment of pelvic pain caused by endometriosis via openalex
- Nafarelin versus danazol in the treatment of endometriosis via openalex
- Nafarelin vs. leuprolide acetate depot for endometriosis. Changes in bone mineral density and vasomotor symptoms. Nafarelin Study Group. via openalex
- One year comparison between two add-back therapies in patients treated with a GnRH agonist for symptomatic endometriosis: a randomized double-blind trial via openalex
- Peritoneal Cellular Immunity and Endometriosis via openalex
- Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis via openalex
- Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up*1 via openalex
- Prolonged gonadotropin-releasing hormone agonist treatment of symptomatic endometriosis: the role of cyclic sodium etidronate and low-dose norethindrone “add-back” therapy via openalex
- Quantification of endometriosis-associated pain and quality of life during the stimulatory phase of gonadotropin-releasing hormone agonist therapy: A double-blind, randomized, placebo-controlled trial via openalex
- Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial. via openalex
- Should add-back therapy for endometriosis be deferred for optimal results? via openalex
- Spontaneous reversibility of bone loss induced by gonadotropin-releasing hormone analog treatment. via openalex
- The effects of combining norethindrone with a gonadotropin‐releasing hormone agonist in the treatment of symptomatic endometriosis via openalex
- The efficacy of drugs in the management of endometriosis via openalex
- The Use of GnRH Agonists in the Medical Therapy of Endometriosis in the Woman with Pain via openalex
- Use of GnRH antagonists in the treatment of endometriosis via openalex
- Use of nafarelin versus placebo after reductive laparoscopic surgery for endometriosis via openalex
- Validation study of nonsurgical diagnosis of endometriosis via openalex
- Vascular endothelial growth factor and endometriotic angiogenesis via openalex
- Zoladex (goserelin acetate implant) in the treatment of endometriosis: a randomized comparison with danazol. The Zoladex Endometriosis Study Group. via openalex
- W18374401 via openalex
- W2412382222 via openalex
- W2417044776 via openalex
- W2068643120 via openalex
- W2077563872 via openalex
- W2057746333 via openalex
- W2093303434 via openalex
- W2100281208 via openalex
- W2123876576 via openalex
- W2140246703 via openalex
- W110566743 via openalex
- W2172273432 via openalex
- W2322133447 via openalex
- W2347177325 via openalex
- W2399999566 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00